Robuta

https://boris-portal.unibe.ch/entities/publication/2877060f-7c27-46ac-b160-1d0c1ab5b75e Raltegravir in second-line ART in resource-limited settings. second lineraltegravirartresourcelimited https://legalblogs.wolterskluwer.com/patent-blog/germany-raltegravir-federal-court-of-justice-of-germany-x-zb-217-11-july-2017/ Germany: Raltegravir, Federal Court of Justice of Germany, X ZB 2/17, 11 July 2017 | Kluwer Patent... In this case the Federal Court of Justice (FCJ) allowed a compulsory licence under a patent for a pharmaceutical active ingredient for the first time ever. The... https://pubmed.ncbi.nlm.nih.gov/32722897/ Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global... Among children in LMICs, the initial use of raltegravir has been primarily for post PI-based cART. We found good virological and immunological outcomes despite... https://adisinsight.springer.com/drugsafety/803273829?error=cookies_not_supported&code=948e1433-c627-4b99-b790-47b1e4eba188 Dolutegravir/elvitegravir/raltegravir - AdisInsight In an observational single-centre study, three patients [1 woman and 2 men; exact ages not stated] were described who developed resistance to raltegravir and dolutegravirelvitegravirraltegraviradisinsight https://pubmed.ncbi.nlm.nih.gov/21402547/ A randomized, controlled trial of raltegravir intensification in antiretroviral-treated,... randomized controlled trialraltegravirintensificationantiretroviraltreated https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbd3e1af-81f3-44f6-8e45-652deab7a508&audience=consumer DailyMed - ISENTRESS- raltegravir tablet, film coated dailymedisentressraltegravirtabletfilm https://adisinsight.springer.com/trials/700035782?error=cookies_not_supported&code=5d16eb03-d245-4fb5-a863-67a1ee7631e2 HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy. - AdisInsight This study is designed to determine how quickly HIV-1 is cleared from the blood in treatment-experienced patients beginning a salvage therapy regimen that hivviraldynamicssubjectsinitiating https://pubmed.ncbi.nlm.nih.gov/24349334/ Genetic and non-genetic determinants of raltegravir penetration into cerebrospinal fluid: a single... ClinicalTrials.gov NCT00729924 http://clinicaltrials.gov/show/NCT00729924. https://adisinsight.springer.com/drugsafety/803113502?error=cookies_not_supported&code=d6e61d16-5044-49af-b214-d1f21ea157d9 Raltegravir - AdisInsight A 57-year-old man developed DRESS syndrome following treatment with raltegravir for HIV infection. The man was administered raltegravir for advanced HIV disease raltegraviradisinsight https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-to-market-msds-hiv-drug-raltegravir-in-india/articleshow/30723869.cms?from=mdr Cipla to market MSD's HIV drug 'raltegravir' in India - The Economic Times MSD in India Managing Director K G Ananthakrishnan said the partnership is aligned with the company's commitment towards patients in India. https://adisinsight.springer.com/trials/700238855?error=cookies_not_supported&code=a48dbfbd-4f88-4482-a6b8-bb73d29d0a70 Pharmacokinetic Drug-drug Interaction Study Between RaltEgravir and CITALopram in Healthy Subjects... This study will investigate the effects of co-administration of raltegravir and citalopram on the pharmacokinetics of both drugs in volunteers. Tolerability drug interactionpharmacokineticstudy https://researchdiscovery.drexel.edu/esploro/outputs/journalArticle/No-Effect-of-Raltegravir-Intensification-on/991019335326304721 No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of... Mar 1, 2012 - Background: Controversy continues regarding the extent of ongoing viral replication in HIV-1-infected patients on effective antiretroviral therapy (ART).... no effect https://pubmed.ncbi.nlm.nih.gov/30999834/ Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and... Raltegravir (RAL) is an HIV-1 integrase strand transfer inhibitor that is well established as a component of highly active antiretroviral therapy regimens for... efficacy and safetyin treatmentabacavir